Another fragment derived from NT-proANP, the proANP 31–67 peptide, has shown cardiorenal protective actions in a preclinical model of hypertension-mediated organ damage with cardiac hypertrophy and renal damage [112]. The gene discussed is NPPA; the disease is cardiac hypertrophy.